Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

Autor: Shefali Thanawala, Rajat Shah, Vasu Karlapudi, Prabakaran Desomayanandam, Arun Bhuvanendran

Publikováno v: Evidence-based complementary and alternative medicine : eCAM. 2022

Background. Delayed onset of muscle soreness (DOMS) and its physiological consequences influenced an individual’s adherence to an exercise routine. Objective. This study aimed to evaluate the efficacy, safety, and tolerability of TurmXTRA® 60N (WD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402982e0fcc8e73a556c1735b9e84765
https://pubmed.ncbi.nlm.nih.gov/35966736

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain.

Autor: Thanawala, Shefali, Shah, Rajat, Somepalli, Venkateswarlu, Alluri, KrishnaRaju Venkata, Desomayanandam, Prabakaran, Bhuvanendran, Arun

Publikováno v: Clinical Pharmacology; May2021, Vol. 13, p91-100, 10p

Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial.

Autor: Thanawala S; Nutriventia, Inventia Healthcare Ltd., Mumbai, India., Shah R; Nutriventia, Inventia Healthcare Ltd., Mumbai, India., Karlapudi V; Pujitha Hospital, Vijayawada, India., Desomayanandam P; In Vitro Research Solutions (iVRS) Pvt Ltd, Bengaluru, India., Bhuvanendran A; In Vitro Research Solutions (iVRS) Pvt Ltd, Bengaluru, India.

Publikováno v: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Aug 05; Vol. 2022, pp. 9110414. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).